Essential Hypertension
|
0.010 |
Biomarker
|
disease |
BEFREE |
No association was observed between the HMOX2 gene and EH.
|
19886851 |
2009 |
Trichohepatoenteric Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These results provide preliminary evidence to suggest a distinction in the genetic background of the subpopulations studied, inferring that the ferritin light-chain gene genotype confers susceptibility to ARDS, while the heme oxygenase 2 haplotype is protective against the onset of the syndrome.
|
17989163 |
2008 |
Acute Erythroblastic Leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Here we show that hypoxia (1% oxygen) reduces the expression levels of heme oxygenase-2 mRNA and protein after 48 h of incubation in human cell lines, including Jurkat T-lymphocytes, YN-1 and K562 erythroleukemia, HeLa cervical cancer, and HepG2 hepatoma, as judged by northern blot and western blot analyses.
|
16787441 |
2006 |
Adult Erythroleukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Here we show that hypoxia (1% oxygen) reduces the expression levels of heme oxygenase-2 mRNA and protein after 48 h of incubation in human cell lines, including Jurkat T-lymphocytes, YN-1 and K562 erythroleukemia, HeLa cervical cancer, and HepG2 hepatoma, as judged by northern blot and western blot analyses.
|
16787441 |
2006 |
Erythroleukemia (Erythroid/Myeloid)
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Here we show that hypoxia (1% oxygen) reduces the expression levels of heme oxygenase-2 mRNA and protein after 48 h of incubation in human cell lines, including Jurkat T-lymphocytes, YN-1 and K562 erythroleukemia, HeLa cervical cancer, and HepG2 hepatoma, as judged by northern blot and western blot analyses.
|
16787441 |
2006 |
Transient Ischemic Attack
|
0.010 |
Biomarker
|
disease |
BEFREE |
Heme oxygenase-2 acts to prevent neuronal death in brain cultures and following transient cerebral ischemia.
|
10974422 |
2000 |
Transient Cerebral Ischemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Heme oxygenase-2 acts to prevent neuronal death in brain cultures and following transient cerebral ischemia.
|
10974422 |
2000 |
Amyotrophic Lateral Sclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Spinal cord motor neurons in both control and ALS mice stained positive for heme oxygenase-2 (HO-2).
|
9527889 |
1998 |
Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In a human glioblastoma cell line, T98G, treatment with any of three types of NO donors--sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-L-glutathione--caused a significant increase in the levels of heme oxygenase-1 mRNA but not in the levels of heme oxygenase-2 and heat-shock protein 70 mRNAs.
|
8764571 |
1996 |
Adult Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In a human glioblastoma cell line, T98G, treatment with any of three types of NO donors--sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-L-glutathione--caused a significant increase in the levels of heme oxygenase-1 mRNA but not in the levels of heme oxygenase-2 and heat-shock protein 70 mRNAs.
|
8764571 |
1996 |
Childhood Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In a human glioblastoma cell line, T98G, treatment with any of three types of NO donors--sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-L-glutathione--caused a significant increase in the levels of heme oxygenase-1 mRNA but not in the levels of heme oxygenase-2 and heat-shock protein 70 mRNAs.
|
8764571 |
1996 |
Glioblastoma Multiforme
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In a human glioblastoma cell line, T98G, treatment with any of three types of NO donors--sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-L-glutathione--caused a significant increase in the levels of heme oxygenase-1 mRNA but not in the levels of heme oxygenase-2 and heat-shock protein 70 mRNAs.
|
8764571 |
1996 |